• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Chest CTA/leg CT combo affords better PE detection

Article

A multicenter study funded by the National Heart, Lung, and Blood Institute says that combining a CT scan of the legs with chest CT angiography increases the chances of detecting pulmonary embolism.

A multicenter study funded by the National Heart, Lung, and Blood Institute says that combining a CT scan of the legs with chest CT angiography increases the chances of detecting pulmonary embolism.

Researchers from eight clinical centers compared three ways to diagnose blood clots in 824 patients suspected of having PE: chest CT angiography alone, chest CTA with venous-phase imaging (leg CT), and chest CTA with an objective clinical assessment known as the Wells Score. The combined chest CTA and leg CT approach provided PE detection and specificity rates of 90% and 95%, respectively. A high clinical probability combined with positive chest CTA correctly indicated PE in 96% of participants. However, a negative chest CTA on these patients did not confidently rule out PE.

The study appeared in the June 1 issue of the New England Journal of Medicine.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.